Clinical Pharmacology Podcast with Nathan Teuscher
By Nathan Teuscher
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Nathan Teuscher
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 5
Reviews: 0
Episodes: 44
Description
I discuss clinical pharmacology and pharmacometrics topics from the perspective of drug development scientists. I share my expertise and knowledge about designing and conducting clinical pharmacology studies and discuss how to analyze the data using the most effective approaches. I draw from my experience of over 20 years working in drug development organizations and consultancies.
| Episode | Date |
|---|---|
|
Different estimation methods used in modeling (Ep. 44)
|
Apr 21, 2025 |
|
What is consulting life like? (Ep. 43)
|
Mar 24, 2025 |
|
Population PK modeling with nlmixr (Ep. 42)
|
Feb 24, 2025 |
|
Sample size calculations (Ep. 41)
|
Jan 31, 2025 |
|
Collaboration with BioTalk Unzipped (Ep. 40)
|
Dec 30, 2024 |
|
Toxicokinetics (Ep. 39)
|
Dec 09, 2024 |
|
Steady State (Ep. 38)
|
Nov 25, 2024 |
|
Dose Proportionality (Ep. 37)
|
Nov 11, 2024 |
|
Covariate Search Methods (Ep. 36)
|
Oct 28, 2024 |
|
Stimulatory Indirect Response PK-PD Models (Ep. 35)
|
Oct 14, 2024 |
|
Inhibitory Indirect Response PK-PD Models (Ep. 34)
|
Sep 23, 2024 |
|
Effect compartment PK-PD models (Ep. 33)
|
Sep 09, 2024 |
|
Direct effect PKPD models (Ep. 32)
|
Aug 26, 2024 |
|
What should you use to present PK results? (Ep. 31)
|
Aug 12, 2024 |
|
How important is terminal rate constant? (Ep. 30)
|
Jul 22, 2024 |
|
Parellelization in modeling (Ep. 29)
|
Jul 08, 2024 |
|
Residual errors and submission packages (Ep. 28)
|
Jun 24, 2024 |
|
Simulations (Ep. 27)
|
Jun 10, 2024 |
|
Different work environments (Ep. 26)
|
May 27, 2024 |
|
Biosimilar products (Ep. 25)
|
May 13, 2024 |
|
Choosing an absorption model (Ep. 24)
|
Apr 22, 2024 |
|
What is Aplos NCA? (Ep. 23)
|
Apr 08, 2024 |
|
Big announcement and Hepatic impairment studies (Ep. 22)
|
Mar 25, 2024 |
|
Project Optimus (Ep. 21)
|
Mar 11, 2024 |
|
Tackling TMDD Models (Ep. 20)
|
Feb 26, 2024 |
|
Communication for scientists (Ep. 19)
|
Feb 12, 2024 |
|
Cell Therapy and Clinical Pharmacology (Ep. 18)
|
Jan 22, 2024 |
|
Allometry in Pediatrics and First in Human Studies (Ep. 17)
|
Jan 08, 2024 |
|
Computer System Validation for Pharmacometrics (Ep. 16)
|
Dec 25, 2023 |
|
QSP, PBPK, PKPD, PopPK … analysis abbreviation soup! (Ep. 15)
|
Dec 11, 2023 |
|
Handling BLQ samples (Ep. 13)
|
Nov 27, 2023 |
|
Clinical Drug Interaction Studies (Ep. 14)
|
Nov 27, 2023 |
|
PK in patients with impaired renal function (Ep. 12)
|
Oct 23, 2023 |
|
Model diagnostics and selection (Ep. 11)
|
Oct 09, 2023 |
|
Exposure-Response FDA Guidance (Ep. 10)
|
Sep 25, 2023 |
|
Finding a job in Clinical Pharmacology (Ep. 9)
|
Sep 11, 2023 |
|
QT Prolongation Guidance ICH E14 (Ep. 8)
|
Aug 28, 2023 |
|
Pediatric Extrapolation (Ep. 7)
|
Aug 14, 2023 |
|
Bioequivalence Guidances from FDA and EMA (Ep. 6)
|
Jul 24, 2023 |
|
Nuances of NCA (Ep. 5)
|
Jul 10, 2023 |
|
Population PK FDA guidance (Ep. 4)
|
Jul 03, 2023 |
|
Comparing NCA and PK models (Ep. 3)
|
Jul 03, 2023 |
|
Food Effect FDA Guidance (Ep 2)
|
Jul 03, 2023 |
|
Podcast about clinical pharmacology (Ep 1)
|
Jul 03, 2023 |